Skip to content

Clinical study on the value of sublingual microcirculatory monitoring to guide early and precise fluid resuscitation in septic shock

Clinical study on the value of sublingual microcirculatory monitoring to guide early and precise fluid resuscitation in septic shock

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064143
Enrollment
Unknown
Registered
2022-09-27
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Interventions

Sublingual microcirculation group:sublingual microcirculation monitoring
EGDT group:Early goal-directed fluid resuscitation therapy

Sponsors

The Second People’s Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 85 years; 2. Meet the diagnostic criteria for Septic Shock: (1) Meeting the definition of sepsis 3.0: sepsis is defined as life-threatening organ dysfunction due to a dysregulated host response caused by infection, i.e. infection (clinical diagnosis) + SOFA >= 2 points; (2) Combined persistent hypotension, requiring vasoactive agents to maintain MAP >= 65 mmHg despite adequate fluid resuscitation; 3. Compliance with the Declaration of Helsinki and Chinese regulations for clinical trial studies, and informed and consenting participation by the patient or his/her family.

Exclusion criteria

Exclusion criteria: 1. Pregnant, persistent epilepsy, acute haematological malignancies, advanced tumours, pulmonary oedema, persistent asthma, severe acute respiratory distress syndrome, malignant cardiac arrhythmias, structural cardiac abnormalities (e.g., severe valvular disease, atrial septal/ventricular septal defects) and other conditions where there is a contraindication to treatment or potential to affect haemodynamic status; 2. Those with cardiogenic shock, haemorrhagic shock and other types of shock; 3. Those requiring emergency surgical treatment; 4. The presence of contraindications to the placement of a central venous catheter; 5. The presence of tongue injury, inflammation and other conditions affecting sublingual microcirculation monitoring; 6. Abandonment of continued treatment; 7. Those who, in the opinion of the investigator, are not suitable for inclusion in the group.

Design outcomes

Primary

MeasureTime frame
Variation of Sequential Organ Failure Score in 72 hours;

Secondary

MeasureTime frame
28-day mortality;Total 24-hour fluid intake;Length of ICU stay;

Countries

China

Contacts

Public ContactZhe Deng

The Second People’s Hospital of Shenzhen

liqiming231@hotmail.com15815520928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026